InsiderTrades

Form 4 for EW Edwards Lifesciences

Accepted 2021-12-10 00:00:00 ET · period of report 2021-12-10 · accession 0001225208-21-014809 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-12-10 2021-12-10 EW WANG HUIMIN CVP, Japan, Intercontinental M - OptEx $21.76 +6,350 104.4K +6% +$138.2K
DM 2021-12-10 2021-12-10 EW WANG HUIMIN CVP, Japan, Intercontinental S - Sale+OE $121.50 -6,350 104.0K -6% -$771.5K
D 2021-12-10 2021-12-10 EW WANG HUIMIN CVP, Japan, Intercontinental M - OptEx $0.00 -6,350 12.7K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-12-10 M A 6,350 $21.76 104,376.89 D — —
2 Common Common Stock 2021-12-10 S D 5,950 $121.46 98,026.89 D — — (F3) This transaction was executed in multiple trades at prices ranging from $121.01 to $121.88. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
3 Common Common Stock 2021-12-10 S D 400 $122.04 103,976.89 D — — (F2) This transaction was executed in multiple trades at prices ranging from $122.01 to $122.09. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
4 Derivative Employee Stock Option (Right to Acquire) 2021-12-10 M D 6,350 $0.00 12,700 D $21.76 · 2015-06-14 to 2022-05-13 6,350 Common Stock